405 related articles for article (PubMed ID: 10558954)
1. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use.
Ma L; Borio L; Masur H; Kovacs JA
J Infect Dis; 1999 Dec; 180(6):1969-78. PubMed ID: 10558954
[TBL] [Abstract][Full Text] [Related]
2. Genetic diversity of drug targets including dihydropteroate synthase, dihydrofolate reductase and cytochrome b, in Pneumocystis carinii f. sp. hominis isolates in Japan.
Takahashi T; Kanda T; Iwamoto A
Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):159-76. PubMed ID: 15080506
[TBL] [Abstract][Full Text] [Related]
3. Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients.
Kazanjian P; Armstrong W; Hossler PA; Burman W; Richardson J; Lee CH; Crane L; Katz J; Meshnick SR
J Infect Dis; 2000 Aug; 182(2):551-7. PubMed ID: 10915088
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the dihydropteroate synthase gene of human-derived Pneumocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis.
Ma L; Kovacs JA; Cargnel A; Valerio A; Fantoni G; Atzori C
J Infect Dis; 2002 May; 185(10):1530-2. PubMed ID: 11992293
[TBL] [Abstract][Full Text] [Related]
5. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients.
Kazanjian P; Locke AB; Hossler PA; Lane BR; Bartlett MS; Smith JW; Cannon M; Meshnick SR
AIDS; 1998 May; 12(8):873-8. PubMed ID: 9631140
[TBL] [Abstract][Full Text] [Related]
6. Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P carinii pneumonia in patients with HIV-1: a prospective study.
Navin TR; Beard CB; Huang L; del Rio C; Lee S; Pieniazek NJ; Carter JL; Le T; Hightower A; Rimland D
Lancet; 2001 Aug; 358(9281):545-9. PubMed ID: 11520525
[TBL] [Abstract][Full Text] [Related]
7. Genetic divergence of the dihydrofolate reductase and dihydropteroate synthase genes in Pneumocystis carinii from 7 different host species.
Ma L; Imamichi H; Sukura A; Kovacs JA
J Infect Dis; 2001 Nov; 184(10):1358-62. PubMed ID: 11679931
[TBL] [Abstract][Full Text] [Related]
8. Contribution of dihydropteroate synthase gene typing for Pneumocystis carinii f.sp. hominis epidemiology.
Santos LD; Lacube P; Latouche S; Kac G; Mayaud C; Marteau M; Poirot JL; Maury E; Guillot J; Roux P
J Eukaryot Microbiol; 1999; 46(5):133S-134S. PubMed ID: 10519287
[No Abstract] [Full Text] [Related]
9. Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance.
Huang L; Crothers K; Atzori C; Benfield T; Miller R; Rabodonirina M; Helweg-Larsen J
Emerg Infect Dis; 2004 Oct; 10(10):1721-8. PubMed ID: 15504256
[TBL] [Abstract][Full Text] [Related]
10. Rapid detection of mutations in the human-derived Pneumocystis carinii dihydropteroate synthase gene associated with sulfa resistance.
Ma L; Kovacs JA
Antimicrob Agents Chemother; 2001 Mar; 45(3):776-80. PubMed ID: 11181359
[TBL] [Abstract][Full Text] [Related]
11. Low prevalence of DHFR and DHPS mutations in Pneumocystis jirovecii strains obtained from a German cohort.
Suárez I; Roderus L; van Gumpel E; Jung N; Lehmann C; Fätkenheuer G; Hartmann P; Plum G; Rybniker J
Infection; 2017 Jun; 45(3):341-347. PubMed ID: 28303545
[TBL] [Abstract][Full Text] [Related]
12. Dihydrofolate reductase gene polymorphisms in Pneumocystis carinii f. sp. hominis in Japan.
Takahashi T; Endo T; Nakamura T; Sakashita H; Kimura K; Ohnishi K; Kitamura Y; Iwamoto A
J Med Microbiol; 2002 Jun; 51(6):510-515. PubMed ID: 12018659
[TBL] [Abstract][Full Text] [Related]
13. High Prevalence of Pneumocystis jirovecii Dihydropteroate Synthase Gene Mutations in Patients with a First Episode of Pneumocystis Pneumonia in Santiago, Chile, and Clinical Response to Trimethoprim-Sulfamethoxazole Therapy.
Ponce CA; Chabé M; George C; Cárdenas A; Durán L; Guerrero J; Bustamante R; Matos O; Huang L; Miller RF; Vargas SL
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855071
[TBL] [Abstract][Full Text] [Related]
14. Pneumocystis carinii dihydropteroate synthase mutations and treatment with sulfa or sulfone regimens: a proposal for standardized definitions for clinical evaluation.
Huang L; Morris AM; Beard CB
J Eukaryot Microbiol; 2001; Suppl():180S-181S. PubMed ID: 11906054
[No Abstract] [Full Text] [Related]
15. Failure of co-trimoxazole in Pneumocystis carinii infection and mutations in dihydropteroate synthase gene.
Mei Q; Gurunathan S; Masur H; Kovacs JA
Lancet; 1998 May; 351(9116):1631-2. PubMed ID: 9620722
[No Abstract] [Full Text] [Related]
16. Study of DHPS and DHFR genes of Pneumocystis jirovecii in Thai HIV-infected patients.
Siripattanapipong S; Leelayoova S; Mungthin M; Worapong J; Tan-Ariya P
Med Mycol; 2008 Jun; 46(4):389-92. PubMed ID: 18415849
[TBL] [Abstract][Full Text] [Related]
17. Relationship between mutations in dihydropteroate synthase of Pneumocystis carinii f. sp. hominis isolates in Japan and resistance to sulfonamide therapy.
Takahashi T; Hosoya N; Endo T; Nakamura T; Sakashita H; Kimura K; Ohnishi K; Nakamura Y; Iwamoto A
J Clin Microbiol; 2000 Sep; 38(9):3161-4. PubMed ID: 10970350
[TBL] [Abstract][Full Text] [Related]
18. Dihydropteroate synthase and novel dihydrofolate reductase gene mutations in strains of Pneumocystis jirovecii from South Africa.
Robberts FJ; Chalkley LJ; Weyer K; Goussard P; Liebowitz LD
J Clin Microbiol; 2005 Mar; 43(3):1443-4. PubMed ID: 15750128
[TBL] [Abstract][Full Text] [Related]
19. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.
Warnock AC; Rimland D
Pharmacotherapy; 1996; 16(6):1030-8. PubMed ID: 8947975
[TBL] [Abstract][Full Text] [Related]
20. [New aspects of epidemiology and treatment of Pneumocystis carinii infection].
Powierska-Czarny J; Gospodarek E; Czerwionka-Szaflarska M
Pol Merkur Lekarski; 2004 Nov; 17(101):534-7. PubMed ID: 15754652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]